# Vizamyl

NDC: 17156-067
Generic name: Flutemetamol F-18
Labeler / Manufacturer: GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140101

FDA application: NDA203137

## Active ingredients

- FLUTEMETAMOL F-18: 4.05 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"17156-067"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=17156-067
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b3558f16-8f9a-4e55-8d9c-836427ebaa57